Lv4
768 积分 2022-02-16 加入
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American Heart Association Scientific Sessions
9小时前
求助中
Impact of Early, Delayed, or Interrupted Treatment in Children With Familial Hypercholesterolemia
9小时前
求助中
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial
14小时前
求助中
Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)
14天前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
14天前
已关闭
Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia
15天前
已完结
Heterogeneous nature of severe hypertriglyceridemia in childhood
21天前
已完结
Severe Hypercholesterolemia in a Pediatric Cohort: Familial Homozygous and Autosomal Recessive Hypercholesterolemia
21天前
已完结
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
26天前
已完结
A practical guide to the management of dyslipidaemia
26天前
已完结
皖公网安备34019202002308
